Sage Therapeutics Stock Forecast

Stock Price Forecast

The 18 analysts with 12-month price forecasts for Sage Therapeutics stock have an average target of 18.06, with a low estimate of 8.00 and a high estimate of 52. The average target predicts an increase of 140.80% from the current stock price of 7.50.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$8.00	$18.06	$17	$52
Change	+6.67%	+140.80%	+126.67%	+593.33%

* Price targets were last updated on Aug 14, 2024.

Analyst Ratings

The average analyst rating for SAGE stock from 19 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Apr '24	May '24	Jun '24	Jul '24	Aug '24	Sep '24
Strong Buy	1	1	1	0	0	0
Buy	2	2	2	1	2	2
Hold	13	14	14	16	16	15
Sell	1	1	1	1	1	1
Strong Sell	0	1	1	1	1	1
Total	17	19	19	19	20	19

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joon Lee Truist Securities	Truist Securities	Hold Maintains $18 → $13	Hold	Maintains	$18 → $13	+73.33%	Aug 14, 2024
Anupam Rama JP Morgan	JP Morgan	Hold Maintains $12 → $10	Hold	Maintains	$12 → $10	+33.33%	Aug 6, 2024
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $25	Hold	Reiterates	$25	+233.33%	Aug 2, 2024
Yasmeen Rahimi Piper Sandler	Piper Sandler	Buy Maintains $70 → $52	Buy	Maintains	$70 → $52	+593.33%	Aug 1, 2024
Ami Fadia Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Aug 1, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

39.62M

from 86.46M

-54.17%

from 86.46M

Revenue Next Year

96.78M

from 39.62M

144.27%

from 39.62M

EPS This Year

-6.66

from -9.05

EPS Next Year

-5.17

from -6.66

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	6.87M	1.11B	6.31M	7.69M	86.46M	39.62M	96.78M	187.04M
Revenue Growth	-92.39%	16,123.06%	-99.43%	21.85%	1,024.84%	-54.17%	144.27%	93.26%
EPS	-13.38	11.43	-7.80	-8.98	-9.05	-6.66	-5.17	-3.76
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	21	21	18

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	52.3M	205.0M	550.2M
Avg	39.6M	96.8M	187.0M
Low	33.4M	47.4M	69.4M

Revenue Growth

Revenue Growth	2024	2025	2026
High	-39.5%	417.3%	468.5%
Avg	-54.2%	144.3%	93.3%
Low	-61.4%	19.6%	-28.3%

EPS Forecast

EPS	2024	2025	2026
High	-5.74	-2.60	0.74
Avg	-6.66	-5.17	-3.76
Low	-6.83	-7.10	-7.80

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.